Argentum 47, Inc., a provider of digital marketing solutions, is in talks with a European medical cannabis company that is fully integrated with strategic assets along the entire value chain, including cultivation, processing, and distribution of dry flower and oil derivatives.
"This strategic expansion closely aligns with our mission of building shareholder value and fostering robust and sustainable growth. The surging European medical cannabis market is projected to reach unprecedented heights in the coming years, as an increasing number of countries progressively pass legislation and establish regulatory frameworks to meet the expected rising demand," said Argentum's CEO, Robert Stephenson.
Argentum is striving to capitalize on the European cannabis industry, which is expected to grow significantly in the coming years as more countries legalize medicinal marijuana and its related products.
"The emergence of a legal framework for the industry has created opportunities for manufacturers, retailers, and consumers alike. In an increasingly competitive market, companies will need to innovate to stand out, and we believe that Argentum can deliver by strategically positioning itself to capitalize on this green field opportunity through the acquisition of a cutting-edge medical cannabis cultivation and processing facility that is planned to be operational in the first half of 2024."
For more information:
Argentum 47
www.argq.io